Axiom Investors LLC Grifols Sa Transaction History

Axiom Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$16.86 - $19.67 $1.55 Million - $1.81 Million	-92,120 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$15.4 - $20.16 $32.6 Million - $42.7 Million	-2,117,560 Reduced 95.83%	92,120 $1.6 Million
Q2 2020 Aug 13, 2020	BUY	$18.24 - $21.45 $181,597 - $213,556	9,956 Added 0.45%	2,209,680 $40.3 Million
Q1 2020 May 14, 2020	BUY	$16.28 - $25.63 $11 Million - $17.2 Million	672,944 Added 44.08%	2,199,724 $44.3 Million
Q4 2019 Feb 13, 2020	BUY	$19.57 - $23.52 $29.9 Million - $35.9 Million	1,526,780 New	1,526,780 $35.6 Million

162

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $6.43B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.